Trade Celularity Inc. - CELU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0534 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001096% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.6033 |
| Open | 1.5933 |
| 1-Year Change | -50.35% |
| Day's Range | 1.5733 - 1.6733 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 1.6433 | 0.0500 | 3.14% | 1.5933 | 1.6733 | 1.5633 |
| Apr 23, 2025 | 1.6033 | 0.1300 | 8.82% | 1.4733 | 1.7433 | 1.4733 |
| Apr 22, 2025 | 1.4733 | 0.0100 | 0.68% | 1.4633 | 1.5233 | 1.4433 |
| Apr 21, 2025 | 1.5033 | -0.0500 | -3.22% | 1.5533 | 1.5533 | 1.4433 |
| Apr 17, 2025 | 1.5333 | -0.0400 | -2.54% | 1.5733 | 1.5733 | 1.5333 |
| Apr 16, 2025 | 1.6233 | -0.0500 | -2.99% | 1.6733 | 1.6933 | 1.5833 |
| Apr 15, 2025 | 1.7133 | 0.1000 | 6.20% | 1.6133 | 1.7133 | 1.5633 |
| Apr 14, 2025 | 1.6533 | -0.0300 | -1.78% | 1.6833 | 1.7633 | 1.6133 |
| Apr 11, 2025 | 1.6233 | 0.1300 | 8.71% | 1.4933 | 1.6233 | 1.4933 |
| Apr 10, 2025 | 1.4933 | -0.0800 | -5.08% | 1.5733 | 1.5733 | 1.4733 |
| Apr 9, 2025 | 1.5233 | 0.0200 | 1.33% | 1.5033 | 1.5333 | 1.4033 |
| Apr 8, 2025 | 1.4633 | 0.0600 | 4.28% | 1.4033 | 1.6333 | 1.4033 |
| Apr 7, 2025 | 1.3633 | -0.0200 | -1.45% | 1.3833 | 1.3833 | 1.3033 |
| Apr 4, 2025 | 1.3733 | -0.0700 | -4.85% | 1.4433 | 1.4433 | 1.3433 |
| Apr 3, 2025 | 1.5433 | -0.0200 | -1.28% | 1.5633 | 1.6833 | 1.5233 |
| Apr 2, 2025 | 1.6133 | 0.0000 | 0.00% | 1.6133 | 1.6433 | 1.6033 |
| Apr 1, 2025 | 1.7133 | 0.0700 | 4.26% | 1.6433 | 1.8033 | 1.6433 |
| Mar 31, 2025 | 1.6933 | -0.1000 | -5.58% | 1.7933 | 1.7933 | 1.6533 |
| Mar 28, 2025 | 1.7633 | -0.1100 | -5.87% | 1.8733 | 1.9333 | 1.7433 |
| Mar 27, 2025 | 1.8733 | -0.1100 | -5.55% | 1.9833 | 1.9933 | 1.8333 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Celularity Inc. Company profile
About Celularity Inc
Celularity Inc. is a clinical-stage biotechnology company. The Company is engaged in developing off-the-shelf placental-derived allogeneic T cells engineered with a chimeric antigen receptor (CAR) (CAR-T) cells, natural killer (NK) cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, infectious and degenerative diseases. It has four placental-derived allogeneic cell types: T cells, unmodified NK cells, genetically modified NK cells and ASCs, which resulted in four key cell therapeutic programs: CyCART-19, CYNK-001, CYNK-101 and APPL-001, focused on six initial indications. Its CyCART-19 is a placental-derived CAR-T cell therapy, in development for the treatment of B-cell malignancies, initially targeting the CD19 receptor. CYNK-001 is developing for the treatment of acute myeloid leukemia (AML), a blood cancer, and for glioblastoma multiforme (GBM), a solid tumor cancer, and COVID-19.
Financial summary
BRIEF: For the six months ended 30 June 2021, Celularity Inc revenues was not reported. Net income totaled $30.9M vs. loss of $5.7M. Net income reflects Change in fair value of warrant liabilit increase from $6.6M (expense) to $34.5M (income), Unrealized gain on marketable securities decrease from $42K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.16 to $0.70.
| Industry: | Bio Therapeutic Drugs |
170 Park Ave
FLORHAM PARK
NEW JERSEY 07932
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com